TrialNeuro-oncology2025

Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial.

Isaias Hernández-Verdin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.